Registered entities
CRISPR THERAPEUTICS, INC.
Reg. No. 473173478United States
Crispr Therapeutics Ag
Reg. No. 1674416United States
Social engagement
Social engagement: 111.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Vertex Pharmaceuticals, Franklin Templeton Investments, New Leaf Venture Partners, Wellington; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 5 | 42% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
3 Mar 2026 · Senior Manager, Supply Chain · Boston
19 Nov 2025 · Senior Manager/Associate Director, Business Development · Boston
17 Jun 2025 · Medical Writer/Senior Medical Writer · Boston
Based on job postings tracked across public sources.
Recent activity
4 May 2026
Milestone
revenue
20 Apr 2026
Recognition
12 Feb 2026
Milestone
revenue